PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,701 stories, page 756 of 779

Advanced search
🌍Industrygedeonrichter.comTier 3 · Secondary coverage

Recept nélkül kapható készítmények

Gedeon Richter (EN)Original source
🌍Industrygedeonrichter.comTier 3 · Secondary coverage

Női egészség

Gedeon Richter (EN)Original source
🌍Industrygedeonrichter.comTier 3 · Secondary coverage

Központi idegrendszer

Gedeon Richter (EN)Original source
🌍Industrygedeonrichter.comTier 3 · Secondary coverage

Kutatás-fejlesztés

Gedeon Richter (EN)Original source
🌍Industrygedeonrichter.comTier 3 · Secondary coverage

Kereskedelem és marketing

Gedeon Richter (EN)Original source
🌍Industrygedeonrichter.comTier 3 · Secondary coverage

Fenntarthatóság az ellátási láncban

Gedeon Richter (EN)Original source
🌍Industrygedeonrichter.comTier 3 · Secondary coverage

Társaságirányító testületek

Gedeon Richter (EN)Original source
🌍Industrygedeonrichter.comTier 3 · Secondary coverage

Üzleti etika és megfelelőség

Gedeon Richter (EN)Original source
🌍Industrygedeonrichter.comTier 3 · Secondary coverage

Richter Érdemérem Díj

Gedeon Richter (EN)Original source
🌍Industrygedeonrichter.comTier 3 · Secondary coverage

Richter Egészségváros

Gedeon Richter (EN)Original source
🌍Industrygedeonrichter.comTier 3 · Secondary coverage

Richter az Oktatásért

Gedeon Richter (EN)Original source
🌍Industrygedeonrichter.comTier 3 · Secondary coverage

Richter a Nőkért

Gedeon Richter (EN)Original source
🌍Industrygedeonrichter.comTier 3 · Secondary coverage

Munkavállalói kezdeményezések

Gedeon Richter (EN)Original source
🌍Industrygedeonrichter.comTier 3 · Secondary coverage

IUPAC-Richter Gyógyszerkémiai Díj

Gedeon Richter (EN)Original source
🌍Industrygedeonrichter.comTier 3 · Secondary coverage

Társadalmi szerepvállalás

Gedeon Richter (EN)Original source
🌍Industrygedeonrichter.comTier 3 · Secondary coverage

Richter Nyugdíjpénztár

Gedeon Richter (EN)Original source
🌍Industrygedeonrichter.comTier 3 · Secondary coverage

Munkahelyi egészség és biztonság

Gedeon Richter (EN)Original source
🌍Industrygedeonrichter.comTier 3 · Secondary coverage

Felelős marketing

Gedeon Richter (EN)Original source
🇦🇺Researchgarvan.org.auTier 2 · Direct publisher

Read article

Garvan Institute of Medical ResearchOriginal source
🇩🇪Devicesfreseniusmedicalcare.comTier 1 · Company source

Fresenius Medical Care introduces TherapyWise TM analytics for kidney replacement therapy

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.comTier 1 · Company source

Statement Regarding United States Department of Health and Human Services' Release of the Kidney Care National Plan

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.comTier 1 · Company source

Statement Regarding Cybersecurity Incident

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.comTier 1 · Company source

Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.comTier 1 · Company source

Fresenius Medical Care accelerates income growth to 23% in the second quarter of 2026 while advancing its strategic agenda

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.comTier 1 · Company source

Fresenius Medical Care presents new evidence and innovations advancing kidney care at ASN Kidney Week 2026

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.comTier 1 · Company source

Fresenius Medical Care Announces Publication of a Multinational Real-World Evidence Study Associating High-Volume Hemodiafiltration with Lower Mortality Risk Than Conventional Hemodialysis

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.comTier 1 · Company source

Interwell Health Delivers Strong Quality Scores and Shared Savings in CMS Value-Based Kidney Care Model

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.comTier 1 · Company source

Fresenius Medical Care Refines China Commercial Strategy with a Focus on Long-Term Growth and Market Leadership

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.comTier 1 · Company source

Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.comTier 1 · Company source

Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.comTier 1 · Company source

Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.comTier 1 · Company source

Fresenius Medical Care Brings Kidney Care Innovation to Critical Care Patients with U.S. Launch of multiFiltratePRO ™

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.comTier 1 · Company source

Fresenius Medical Care appoints Cassie McLean as new Management Board Member for Care Delivery

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.comTier 1 · Company source

Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.comTier 1 · Company source

Fresenius Medical Care announces BEACON-US, generating real-world evidence supporting high-volume hemodiafiltration for U.S. dialysis patients

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.comTier 1 · Company source

Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.comTier 1 · Company source

Media overview

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.comTier 1 · Company source

Health & Wellness

Fresenius Medical CareOriginal source
🇩🇪Devicesfreseniusmedicalcare.comTier 1 · Company source

High-Volume Hemodiafiltration Remains the Benchmark for Survival Evidence in Dialysis

Fresenius Medical CareOriginal source
🇺🇸Industryfreenome.comTier 1 · Company source

Freenome to Report Third Quarter 2026 Financial Results on November 10, 2026

FreenomeOriginal source
🇺🇸Industryfreenome.comTier 1 · Company source

Perceptive Capital Solutions Corp and Freenome Announce Effectiveness of Registration Statement for Proposed Business Combination

FreenomeOriginal source
🇺🇸Industryfreenome.comTier 1 · Company source

Freenome’s SimpleScreen™ CRC Blood-Based Test Included in Updated ACS Colorectal Cancer Screening Guideline

FreenomeOriginal source
🇺🇸Industryfreenome.comTier 1 · Company source

Freenome to Present New Validation Data for Next Generation CRC Screening Test in Late-Breaking Oral Presentation at ACG 2026

FreenomeOriginal source
🇺🇸Industryfreenome.comTier 1 · Company source

Freenome Reports Top-Line Readout of Updated SimpleScreen™ CRC Colorectal Cancer Screening Blood Test Met All Primary and Secondary Endpoints

FreenomeOriginal source
🇺🇸Industryfreenome.comTier 1 · Company source

Freenome Reports Data for Multiomic Blood-Based Screening Test for Lung Cancer

FreenomeOriginal source
🇺🇸Industryfreenome.comTier 1 · Company source

Freenome Names Aaron Elliott, Ph.D., as Chief Executive Officer to Lead the Company’s Next Chapter of Commercial Growth and Product Innovation

FreenomeOriginal source
🇺🇸Industryfreenome.comTier 1 · Company source

Freenome Expands Personalized Cancer Detection Portfolio, Launching SimpleScreen™ Lung Test With FDA-Approved SimpleScreen CRC Option

FreenomeOriginal source
🇺🇸Industryfreenome.comTier 1 · Company source

Freenome Delivers Improved Performance in Its Colorectal Cancer Blood Test with Sensitivity of 85% for CRC and 22% for Advanced Precancerous Lesions

FreenomeOriginal source
🇺🇸Industryfreenome.comTier 1 · Company source

Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection

FreenomeOriginal source
🇺🇸Industryfreenome.comTier 1 · Company source

Freenome Appoints Linh H. Le as Chief Financial Officer

FreenomeOriginal source
🇺🇸Industryfreenome.comTier 1 · Company source

Freenome Appoints Industry Veteran Rob Guigley as Chief Commercial Officer to Drive Commercial Strategy, As Agreement with Exact Sciences Clears Antitrust Review

FreenomeOriginal source
🇺🇸Industryfreenome.comTier 1 · Company source

Freenome Announces Topline Results for PREEMPT CRC® to Validate the First Version of its Blood-Based Test for the Early Detection of Colorectal Cancer

FreenomeOriginal source
🇺🇸Industryfreenome.comTier 1 · Company source

Freenome Announces JAMA Publication of Data from Pivotal Study of its Blood-Based Test for Colorectal Cancer

FreenomeOriginal source
🇺🇸Industryfreenome.comTier 1 · Company source

Freenome Announces Expanded Artificial Intelligence and Deep Learning Initiatives Accelerated by NVIDIA, to Advance Personalized Multi-Cancer Detection

FreenomeOriginal source
🇺🇸Industryfreenome.comTier 1 · Company source

Freenome Announces Exclusive License Agreement with Exact Sciences to Commercialize Freenome’s Blood-Based Screening Test for Colorectal Cancer

FreenomeOriginal source
🇺🇸Industryfreenome.comTier 1 · Company source

Freenome Announces Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S.

FreenomeOriginal source
🇺🇸Industryfreenome.comTier 1 · Company source

Freenome and Perceptive Capital Solutions Corp Announce Business Combination Agreement to Create a Publicly Listed Company Transforming Blood-Based Multi-Cancer Detection through an AI/ML-Enabled Multiomics Platform

FreenomeOriginal source
🇺🇸Industryfreenome.comTier 1 · Company source

FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based SimpleScreen™ Lung Cancer Screening Test

FreenomeOriginal source
🇺🇸Industryfreenome.comTier 1 · Company source

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.

FreenomeOriginal source
🌍Investorfrazierhealthcare.comTier 2 · Direct publisher

Pairing Fast Growing Companies with Industry Leaders

Frazier Healthcare PartnersOriginal source